The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 28, Issue SUPP. 3, 2008, Pages

  Do, Jun Young ^a   Kim, Yong Lim ^b   Park, Jong Won ^a   Chang, Kyung Ae ^a   Lee, Seung Hyun ^a   Ryu, Dong Han ^a   Kim, Chan Duk ^b   Park, Sun Hee ^b   Yoon, Kyung Woo ^a  

^a Young Nam University Hospital   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

CA125; Cancer antigen 125; EMT; Epithelial to mesenchymal transition; GDPs; Glucose degradation products; Peritoneal growth factors

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; FIBRONECTIN; GENE PRODUCT; GLUCOSE DEGRADATION PRODUCT; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED GENE PRODUCT H 3; VASCULOTROPIN;

ADULT; AGED; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIALYSATE LEVEL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; PERITONEUM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL MARKERS; CA-125 ANTIGEN; CELL CULTURE TECHNIQUES; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; GLUCOSE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48749121525     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
2. Do JY, Kim YL, Park JW, Cho KH, Kim TW, Yoon KW, et al. The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2005; 25(Suppl 3):S14-17.
3. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. IsoLation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
4. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
5. Kim YL, Do JY, Park SH, Cho K, Park J, Yoon K, et al. Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report. Nephrology (Carlton) 2003; 8(Suppl):S28-32.
6. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23:530-41.
7. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46:938-48.
8. Ýñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
9. Selgas R, Bajo A, Jiménez-Heffernan JA, Sánchez-Tomero JA, Del Peso G, Aguilera A, et al. Epithelial-to-mesenchymal transition of the mesothelial cell - its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 2006; 21(Suppl 2):ii2-7.
10. López-Cabrera M, Aguilera A, Aroeira LS, Ramírez-Huesca M, Pérez-Lozano ML, Jiménez-Heffernan 3A, et al. Exvivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 2006; 26:26-34.
11. Topley N, Michael D, Bowen T. CA125: holy grail or a poisoned chalice. Nephron Clin Pract 2005; 100:c52-4.
12. Breborowicz A, Breborowicz M, Pyda M, Polubinska A, Oreopoulos D. Limitations of CA125 as an index of peritoneal mesothelial cell mass. Nephrol Clin Pract 2005; 100:c46-51
13. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15:1-12.